Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion Capital Partners, a Netherlands-based life sciences venture capital firm with a long track record of backing European biotechnology and healthcare companies. The SPAC completed its initial public offering in 2021 and was structured to target acquisition opportunities in the life sciences and healthcare sectors, with a primary focus on European-headquartered businesses. The company filed an amended current report on Form 8-K/A with the SEC on May 22, 2023, accession number 0001193125-23-150633, reflecting updated disclosures related to its ongoing corporate activities. Investors and analysts seeking comprehensive filing history, sponsor background, and transaction timelines for FRBN can access the full dataset by signing up at SpacDesk.